Business Terms Cancer Prognoses Informed by Module-Based Approach, Study Finds Researchers highlight patient survival and other prognostic clues that can be drawn from expression data and related module-based molecular analyses on several cancer types. New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux New products and services posted to GenomeWeb for the week of Jan. 30, 2023. Genetic Technologies to Raise A$5M in Direct Stock Offering The firm said several institutional investors had inked definitive agreements for the purchase and sale of 3,846,155 American Depositary Shares. Bionano Genomics Obtains China NMPA Approval for DNA Extraction, Labeling Products Premium Through its OEM partner, the company secured NMPA registrations for IVD use in China for its bone marrow aspirate DNA exaction kit and its DNA staining reagents. In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More News items for the week of Jan. 30, 2023. Feb 3, 2023 MDxHealth Prices $40M Public Offering Feb 3, 2023 Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates Feb 3, 2023 All of Us Researchers Make Case for Long Reads in Population Sequencing Premium Feb 3, 2023 Personalis, Moderna Collaborate on mRNA Cancer Vaccine Development Feb 2, 2023 UBS Initiates Coverage of 10X Genomics, PacBio, Akoya Biosciences, NanoString Technologies Feb 2, 2023 Circadian Gene Expression Variation Across Tissue Types May Offer Aging, Disease Clues Feb 2, 2023 Siemens Healthineers Q1 Dx Revenues Fall 21 Percent; Firm Strikes Lab Analyzer Deal With Unilabs Feb 2, 2023 Becton Dickinson Fiscal Q1 Revenues Down 3 Percent; Firm Raises FY23 Guidance Feb 2, 2023 NanoString Technologies, Weill Cornell Medicine Collaborate on Spatial Atlas of Human Tissues Feb 2, 2023 Roche Diagnostics Revenues Essentially Flat in 2022 Feb 2, 2023 Ireland Outlines National Strategy to Streamline Access to Genomic Medicine Premium Feb 2, 2023 Bio-Techne Fiscal Q2 Revenues Inch up as Protein Business Lags but Genomics Boom Feb 2, 2023 Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Feb 2, 2023 Universal DX Eyeing Approval for Colorectal Cancer Early Detection Test After Positive Data Premium Feb 2, 2023 Hologic Fiscal Q1 Revenues Fall 27 Percent as COVID-19 Assay Sales Continue Slide Feb 1, 2023 Immunexpress Begins US Commercialization of Near-Patient Sepsis Diagnostic Test Premium Feb 1, 2023 SolveBio Acquisition Fuels QuartzBio's Ambitions in Biomarker Discovery Premium Feb 1, 2023 Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Feb 1, 2023 Metastatic Tumor Subtypes Found With Expression Profiling Feb 1, 2023 Thermo Fisher Scientific Clinical Research Business Delivers Strong Results in First Full Year Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.